| 摘要 |
Use of xenaldial, xenalemine and xenalic acid for the treatment of HIV infections and related conditions, particularly AIDS. The invention also relates to pharmaceutical compositions in the form of combined preparations, comprising a compound selected from the group of xenaldial, xenalamine and xenalic acid, and at least an anti-HIV agent selected from the group of protease inhibitors, revers transcriptase inhibitors and integrase inhibitors. |
